RSS Feed

Tech

On this randomised, open-label, three-arm trial, median development-free survival (PFS), the size of time a affected person lives from research randomisation to disease development or demise was the primary endpoint of the research.  Also visit my site -  https://bookmarking.win/story.php?title=medicine-intervention-treatments